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Abstract
There are approximately 5.7 million Americans currently living with Alzheimer’s
Disease (AD). Early detection of cognitive impairment allows for earlier treatment, potentially
slowing or halting cognitive decline. A 30-min web-camera eye tracking assessment (30-min
VPC) has been validated as a tool to predict AD risk. However, a shorter version would allow for
greater scalability and improve user experience. The purpose of this study was to: 1) determine
the validity of the 5-minute web-camera based VPC test with the 30-min test, 2) determine the
test-retest reliability of the 5-min test, 3) compare the 5-minute test scores of cognitively intact
adults (18-39 years of age) to the scores of cognitively intact older adults (>65 years of age), 4)
examine the relationship between the 5-min web camera based VPC test and additional cognitive
tests. This prospective study included two groups, both with normal cognitive function: 24 young
adults (26.5 + 7.4 years) and 20 older adults (79.3 + 6.4). Participants were tested on two
separate occasions. Trial 1 included the Montreal Cognitive Assessment (MoCA), Digit Symbol
Coding, NIH Toolbox Assessment, 30-min VPC, and 5-min VPC. Trial 2 occurred at least 14
days later and participants completed the 5-min VPC, Digit Symbol Coding, NIH Toolbox, and
dual-task walking assessments. The 5-min VPC significantly correlated to the 30-min VPC
during the first (p = .003) and second (p = .001) trial, and showed significant test re-test
reliability (p < .001). The 5-min VPC mean scores were 83% and 80% for Trial 1 and Trial 2,
respectively, with a significant time interaction (p = .04). There was a significant relationship
between the 5-min VPC and DCCS ( p = .03), MoCA (p = .00), and Digit Symbol Coding (p =
.00), during Trial 1. As well as Flanker (p < .01), PCPST (p = .00), PSMT (p < .01), MoCA (p =
.00), and Digit Symbol Coding ( p = .00), during Trial 2. The results from this study suggest the
5-min VPC test is a valid and reliable tool to assess cognitive function.
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Introduction
According to the Alzheimer’s Association (2018), Alzheimer’s Disease (AD) is the sixth
leading cause of death in the United States (US), with approximately 5.7 million Americans
currently living with AD, of which 5.5 million are 65 years of age or older. From 2000 to 2015,
the number of deaths due to heart disease decreased by 11%, whereas the deaths from AD
increased by 123%. This presents the importance of research and education of the general
population, in an effort to decrease the rate of deaths and ideally decrease prevalence of AD
altogether. In 2018 alone, AD and other dementias were estimated to cost the US $277 billion
dollars, with both costs estimated to rise to $1.1 trillion and prevalence estimated to increase to
14 million, by the year 2050. With early detection and accurate diagnosis, up to $7.9 trillion
could be saved in medical and care costs. While there is not currently a cure for AD, studies have
shown various interventions have the ability to slow the progression of the disease (Nelson &
Tabot, 2015; Nganda et al., 2015; Rosenburg et al., 2017). This means early detection of
cognitive decline is crucial.
Cognitive disorders are classified on a spectrum dependent on phenomenological,
epidemiological, clinical, neuropsychological, and biological variables. Mild Cognitive
Impairment (MCI) is the first stage of cognitive decline, characterized as memory loss that
deviates from normal aging (Alistair & Zandig 2002; Zola, Manzanares, Clopton, Lah, & Levey,
2012). The development of MCI puts the individual at a greater risk of developing dementia,
which is a diagnosis of a group of symptoms associated with a decline in memory and thinking
skills, severe enough to interfere with the ability to perform activities of daily living.
Furthermore, AD is a specific disease, within the diagnosis of dementia, that causes a decline in
memory, thinking, and behavior, specifically inhibiting the ability to remember newly learned
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information and affecting mood and behavior (Alzheimer’s Association, 2018). MCI does not
always progress to dementia and the development of dementia varies tremendously between
individuals who do convert (Hayat et al., 2014). However, MCI puts individuals at an increased
risk of developing AD when compared to healthy individuals, with the progression estimated at
6% to 25% per year (Crutcher et al., 2009). Furthermore, AD is the most common cause of
dementia and makes up 60-80% of total dementia cases (Alzheimer’s Association, 2018).
It is common for changes in memory to go undetected for the first 7-10 years. It is
important to know the risk of developing dementia and to detect impairments as soon as possible,
so preventive interventions can be implemented, in an effort to slow the progression of the
disease. This means effective, highly sensitive memory tests are imperative to detect possible
deficiencies, as early as possible (Elias et al., 2000). Visual Paired Comparison (VPC) is a
validated memory recognition test used to compare the amount of time a subject spends viewing
a new/novel image to an image already seen, when displayed side-by-side. Being able to track
these eye movements during VPC and use the results as a screening tool for cognitive
deficiencies, improves the ability to detect early stages of MCI, predict the risk of developing
MCI/dementia, and track cognitive function over time (Crutcher et al., 2009; Daffner, Scinto,
Weintraub, Guinessey, & Mesulam, 1992; Lagun, Manzanares, Zola, Buffalo, & Agichtein,
2011).
A commercial grade eye tracker, which consists of a high frame rate camera, capable of
capturing a number of visual features, has been validated to track and record eye movement
during VPC (Crutcher et al., 2009; Lagun et al., 2011) However, these cameras are expensive,
which led to the validation of web-cameras as an alternative. Web-cameras are readily available
on most portable devices, including laptops, tablets, and phones, which makes them inexpensive
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and accessible to the public (Y. Lin, R. Lin, Y. Lin, & Lee, 2013). A 30-minute VPC eye
tracking assessments, using a built-in web-camera, has been validated (Bott et al., 2017).
However, with the extensive amount of time required for testing, a shorter version of the same
assessment is needed to increase efficiency and improve the ability to use the test as a screening
tool.
Operational Definitions
Cognition encompasses the processes of the brain involved in the ability to gain
knowledge and comprehend, which includes thinking, knowing, remembering, judging, and
problem solving. These functions are used for language, imagination, perception, and the ability
to plan and execute certain behaviors (National Institutes of Health, 2017). MCI is described as
the stage between normal cognitive ageing and dementia. There are clear signs of impairment to
memory when compared to healthy controls, but impairment is less than patients with mild
dementia. Dementia is a non-specific diagnosis used to describe a group of symptoms, including
the decline of cognition and other skills that may impair a person’s ability to perform activities of
daily living. Furthermore, AD is a specific disease within the diagnosis of dementia that causes a
decline in memory, thinking, and behavior, specifically inhibiting the ability to remember newly
learned information (Alzheimer’s Association, 2018). VPC task is a method that displays a series
of two identical images side-by side, which become the familiar images, followed by a series of
slides with a familiar image displayed next to a new/novel image (Crutcher et al., 2009; Daffner
et al., 1992).
Literature Review
MCI, dementia, and AD are all diagnoses for varying levels of cognitive impairment.
MCI is broad term used to describe memory loss, which has been linked to changes in the medial
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temporal lobe, impairing recollection. With MCI, often other cognitive abilities are preserved,
but it does have the potential to develop to dementia. The development of dementia is
multifactorial, including both genetic and environmental factors. Risk factors may include, but
are not limited to; age, alcohol abuse, smoking, hypertension, obesity, dyslipidemia, vascular
damage, and neural damage. However, physical activity, education, and cognitive and social
activities have shown to protect against the development of dementia. The current method for
predicting the risk for developing dementia is the CAIDE (Cardiovascular Risk Factors, Aging
and Dementia) Dementia Risk Score which uses age, education, gender, blood pressure, body
mass index, total cholesterol, and physical activity. The greater the score, the greater the risk of
dementia (Kivipelto et al., 2013).
VPC task recognition aims to detect impairments in memory to predict MCI and AD
development. In 1992, researchers developed an objective measure to define cognitive
impairment by using an infrared light camera to track the pupils of participants. Curiosity slides,
which contain a regular and irregular figure, and incongruous picture slides, a photo containing
an irregular stimulus, such as a lion sitting at a desk in a classroom of children, were used. AD
patients spent significantly less time looking at both the irregular figures and the irregular
portions in the incongruous pictures, when compared to controls who were matched based on
age, education, and work experience (Daffner et al., 1992). The ability to measure, and track
cognitive impairment over time, allows interventions to be tested to determine ways to further
prevent cognitive decline.
Current VPC methods use familiar and novel images to detect impairment. Participants
are shown two identical images, side-by-side, during a familiarization period. With varying time
between stimuli, the testing period displays old and new images, side-by-side. Using both two-
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second delays and two-minute delays between stimuli, Crutcher et al. (2009), compared an MCI
group to a matched Parkinson’s and cognitively intact control group. Results found there was no
significant difference between groups during the two-second delay. However, during the twominute delay, the MCI group spent approximately 53% of total time viewing the new image,
whereas the Parkinson’s and cognitively intact groups spent 71% and 74% of their time on the
new image, respectively. VPC specifically measures the percentage of time spent looking at
novel images, which target declarative memory. These results suggest VPC task has the potential
to be used as a screening tool for detecting impairment. Individuals spending less than 65% of
time looking at the novel image have an increased risk of developing MCI/AD.
In addition to the infrared eye tracking system, Lagun et al. (2011) validated the use of
Support Vector Machines (SVM), which is an automatic classification algorithm. SVM accounts
not only the amount of time spent looking at the novel image verse the familiar image, but also
the time spent on the “grey area” between images. Most importantly, it detects eye movement
patterns, specifically fixations, saccades, and re-fixations. Prior techniques for distinguishing
normal subjects from MCI subjects was 67% accurate, 60% sensitive, and 73% specificity. Using
SVM performance of accuracy, sensitivity, and specificity increased to 87%, 97%, and 77%,
respectively. Potentially, this allows for more sensitive detection of MCI and/or the risk of
developing MCI in participants prior to diagnosis.
These findings attest to the validity of VPC and its ability to differentiate between control
individuals, who have normal cognitive function, and individuals with MCI. A three-year
longitudinal study, using 32 MCI participants and 60 control participants, was used to determine
the ability of VPC to predict which individuals in the control group and which MCI individuals
would or would not progress to develop MCI and/or AD, respectively. At the conclusion of the
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three-year trial, 13 MCI patients developed AD and four control subjects developed MCI, which
placed them in the converter group (CONV). The remaining participants were placed in the nonconverter group (NONCONV). During the VPC task, the scores associated with the percentage
of time looking at the novel image was significantly lower in the CONV group compared to the
NONCONV group, with no significant difference between the CON and MCI participants within
the CONV group. Additionally, when the same scores were compared to a group of 20 patients
with AD, there was no significant difference. Furthermore, both the participants with MCI and
the CON participants in the CONV group had significantly lower VPC mean scores than the
NONCONV group. Most importantly, out of the 43 subjects with a VPC score ≥ 67, there were
zero participants who converted. On the contrary, eight of the nine participants with a VPC score
≤ 50 converted over the three-year span. A receiver-operating characteristic curve using scores
from all the participants showed an area under the curve of .903, which displays a strong ability
for VPC to predict the chances of a participant’s diagnosis changing within the next three years
(Zola et al., 2012).
With the accuracy, sensitivity, and specificity of VPC increasing using advanced
technology, Bott et al. (2017), further investigated the idea of administering VPC using a webcamera, in an effort to make VPC more accessible to the general population. Research eye
tracking cameras not only require a significant amount of setup and maintenance, but also cost
up to $50,000. This has confined VPC testing to research labs, making it difficult to test large
populations. Web-cameras have become standard hardware in smart devices and a readily
available to the general population, without additional costs. Fifty-four clinically normal older
adults completed three trials of VPC while simultaneously recording eye tracking using both the
standard eye tracking camera, scored automatically, which collects 60 frames per second (FPS),
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and the built-in laptop web-camera, scored manually by human coders, collecting three FPS, five
FPS, and ten FPS. With a strong correlation between all three-manual web-camera scores, the
three FPS scores were compared to the standard eye tracking score. The results showed a strong
mean correlation of .76, between the eye tracker camera and the web-camera at three time points.
The web-camera based tasks were also more reliable with only 2.3% of tasks excluded due to
technical issues compared to 10% of the eye tracker-based tasks. The manual recording not only
showed fewer data quality issues, but also showed a strong correlation to the automatic scoring
methods previously used. With web cameras being easily accessible to the population, this
allows for VPC to be administered with minimal costs, while still producing valid and reliable
results.
There is currently no cure, but with early detection, there are interventions aimed at
slowing the progression of AD. Dietary interventions, including the Mediterranean diet and the
Dietary Approaches to Stop Hypertension (DASH), have been shown to produce greater scores
in the Mini-Mental State Examination and improved psychomotor speed, when compared to
controls. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet has
been developed to treat patients with AD. Results showed that high adherence to the previously
mentioned diets, along with moderate adherence to the MIND diet, all showed decreased risk of
AD (Morris et al., 2015). Furthermore, the FINGER multi-domain approach, including diet,
strength and aerobic training, cognitive, and social interventions over a 24-month period was
used in a sample of 1,168 older adults, ages 60-77 years, who were at an increased risk for
developing dementia. Results showed improved executive function, processing speed, memory,
and neurological test scores, compared to the control who received only regular health advice
(Ngandu et al., 2015). Using the same intervention, Rosenburg et al. (2017), found that
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sociodemographic, socioeconomic status, cognition, cardiovascular factors, and cardiovascular
comorbidity did not have an effect on the outcome of the multi-domain intervention. These
interventions can be used in conjunction with the web-camera administration of VPC tasks to
potentially reduce the number of participants who are at a high risk to convert from normal to
MCI and/or MCI to AD.
In order to not only slow the progression of dementia, but to prevent cognitive decline
overall, methods used to detect impairment and measures used to calculate risks for developing
dementia in the future need to be further developed and perfected. Early detection and prevention
are imperative to battle a disease that has no cure.
The purpose of this study was muti-factorial and includes the following: 1) determine the
validity of the 5-minute web-camera based VPC test with the 30-min test, 2) determine the testretest reliability of the 5-min test, 3) compare the 5-minute test scores of cognitively intact adults
(18-39 years of age) to the scores of cognitively intact older adults (>65 years of age), 4)
examine the relationship between the 5-min web camera based VPC test and additional cognitive
tests.
Methodology
Research Design
This was a non-experimental, prospective study. This design compared scores both
within the young adult group (18-39 years of age), and between the young adults and the older
adults (>60 years of age). The independent variable was the age group cohort. The dependent
variables were the 5-min VPC results and the scores of the additional cognitive tests: Montreal
Cognitive Assessment (MoCA), Digit Symbol Coding Test, NIH toolbox assessments, and dualtask results.
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Measures
Demographics. Height was measured, to the nearest 0.5cm, using a standing stadiometer.
Subjects are asked to remove their shoes and stand up as straight as possible. Weight was
measured, to the nearest 0.5kg, using a balance-beam scale. Subjects were asked to remove their
shoes and heavy clothing (sweaters/jackets/coats) and empty their pockets. Body composition
was measured using a dual-energy x-ray absorptiometry (DXA).
MoCA. The Montreal Cognitive Assessment (MoCA) is a paper-pencil test used to
screen for cognitive impairment and assesses multiple cognitive domains. These cognitive
domains include attention and concentration, executive functions, memory, language,
visuoconstructional skills, conceptual thinking, calculations, and orientation. The test takes
approximately 10 minutes, with a possible 30 points. If a score > 26 was obtained, the participant
was categorized as cognitively normal and completed the other assessments. With a score < 26 or
diagnosed with AD, the participant was categorized as cognitively impaired. For these
individuals, the signature of a guardian was required in order to complete the remaining tests.
The ability of the MoCA to identify MCI and dementia has been shown to be 84-90% and 94100% effective, respectively (Nasreddine et al., 2005; Smith, Gildeh, & Holmes, 2007).
Digit Symbol Coding Test. The Digit Symbol Coding Test is a paper-pencil test used to
assess cognition, specifically processing speed and executive functioning. Rows of blank squares
were matched with randomly assigned numbers from one to nine. Above the rows was a
reference key that pairs each number with a different symbol. The reference key was used to pair
as many symbols as possible with the assigned number, within 90 seconds. Digit Symbol Coding
was found to be the best test for screening cognitive impairment, when compared to various
other assessments, with a high test-retest reliability (r = .85) (Gonzalez-Blanch et al., 2011).
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NIH Toolbox. NIH developed an application with a standard set of validated, reliable
tests used to assess neurological and behavioral function. The following tests are within the
cognitive domain of the NIH Toolbox: Flanker Inhibitory Control and Attention, Dimensional
Change Card Sort (DCCS), Pattern Comparison Processing Speed, Picture Sequence Memory.
The tests were administered using an iPad, with the order of test administration to always follow
the order listed above. Prior to the test trials, it was demonstrated how to complete each task, in
addition to a given number of practice sets. If the participant answered at least three out of four
correctly during the practice set, the test began. If less than three were correctly answered, two
additional practice sets were given. However, the test ended if three answers were not correct by
the end of the third practice set (NIH, 2017). When compared to the Gold Standard tests, the NIH
Toolbox has been shown to be a valid and reliable assessment, for adults, of six domains of
cognition: working memory, executive function, episodic memory, processing speed, language
and reading. Each assessment within the NIH toolbox is strongly related to the domain intended,
while also being weakly related to the other domains, which attests to the validity of the toolbox,
in its entirety. There were no differences found, when compared to gold standard measures,
across 20-85 year age groups, allowing for reliable and consistent testing over the course of a
lifetime (Mungas et al., 2014).
Flanker Inhibitory Control and Attention Test. The participant was instructed to focus
on a particular stimulus while inhibiting attention to the stimuli flanking it. A row of arrows was
presented on the screen. Sometimes the arrows were pointing in the same direction and
sometimes the arrows were pointing in different directions. The objective was to select the
button that matches the way the middle arrow was pointing. This was a method used to measure
inhibitory control and attention (NIH, 2017).
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Dimension Change Card Sort Test (DCCS). This is a cognitive test used to measure
flexibility and attention. Two target pictures were presented that vary along two dimensions (ex.,
shape and color). Participants were asked to match a series of bivalent test pictures (ex., yellow
balls and blue trucks) to the target pictures, first according to one dimension (ex., color) and after
numerous trials, according to the other dimension (ex., shape). Instruction on how to match
pictures according to shape were given along with the necessary practice trials. Next, it was
explained how to match the pictures according to color, again followed by the practice items.
The 30-test items are a combination of both matching color and shape dependent on what was
indicated in the middle of the screen (NIH, 2017).
Pattern Comparison Processing Speed Test (PCPST). In order to assess processing
speed, two pictures were presented on the screen side-by-side. If the pictures were identical, the
participants selected the “yes” button and if the pictures were not identical, the participant
selected the “no” button. Six practice items were given before the test begins. With a total of 130
items, the test was completed when all 130 items appear or after 85 seconds have elapsed (NIH,
2017).
Picture Sequence Memory Test (PSMT). Sequences of pictured objects and activities
were presented in a specific order to test episodic memory. The objective was to reproduce the
pictures in the same order they appeared on the screen. It was demonstrated how to drag the
picture on the screen prior to the four-step practice sequence. The test consisted of two trials. The
first trial was a 15-step sequence and the second trial was an 18-step sequence, which included
all 15 pictures from the first trial (NIH, 2017).
Visual Processing Comparison (VPC). The VPC tests (Neurotrack’s 30-min and 5-min
tests) were taken on a laptop equipped with a web-camera. The assessments were recorded and
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the videos of the participants’ face were stored so their eye movements can be tracked. The 5min VPC test is a condensed version of the 30-minute test. Additionally, the 5-min test is active
because it instructs the participant to look at the new image they have not yet seen, whereas the
30-min test is passive and does not instruct the participant what to do while looking at the images
(NIH, 2017). The videos of the participants’ faces were analyzed by Neurotrack technicians.
Dual-task. Cognitive function and the ability to walk are related, meaning cognitive
impairment has an effect on gait ability, which can be measured using dual-task assessments.
Dual-task has shown to be reliable (r ≥ .75) when testing individuals with Parkinson’s disease,
MCI, dementia, AD, and multiple sclerosis (Yang et al., 2017). Dual-task assessment measures
the time it takes to walk 10-meters under various instructions. The first measure was walking at a
normal pace. The second was walking at a fast pace, without jogging. Two trials at each pace
were completed, timed, and recorded. The next measure was at walking at a normal/habitual
pace while counting down by threes from a random number assigned to them. The final was the
same dual-task but at the maximal walking pace. Different random numbers were assigned to
each of the four dual-task trials. Individuals with cognitive impairment had more difficulty
completing the dual-task trials compared to healthy adults, which resulted in increased time to
walk 10-meters (Doi et al., 2014).
Procedures
Once IRB approval was obtained, adults (18-39 years) and older adults (>60 years) with
normal cognitive function, were recruited. A total of 44 participants were used to complete the
study (24 young adults and 20 older adults). The young adults reported to the Exercise Science
Research Center at the University of Arkansas for two separate trials. The older adults completed
the assessments at Butterfield Trail Village. For the first trial, upon arrival, participants
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completed the informed consent document, the medical history questionnaire, and the MoCA, to
screen for cognitive impairment, prior to the administration of the cognitive assessments (Digit
Symbol Coding Test and NIH Toolbox) and the 30-min and 5-min VPC tests.
The order of the cognitive tests remained the same for all trials. However, the participants
were randomly assigned to determine the order of test administration for the cognitive tests and
the VPC tests. During the first trial, if the participant completed the cognitive assessments before
the VPC tests, they were administered the VPC test before the cognitive assessments during the
second trial, and vice versa.
The second trial occurred at least 14 days after the first trial. During the session subjects
repeated the cognitive tests (Digit Symbol Coding Test and the NIH Toolbox) and the 5-min
VPC test. Additionally, dual-task measures and demographics (height, weight, and body
composition) were taken during the second trial.
Data Analysis
To determine the validity of the 5-min test compared to the 30-min VPC and the other
cognitive assessments, a Pearson correlation was used. To determine the test-retest reliability of
the 5-min VPC test, a paired t-test using the day 1 and day 14 data was completed. Additionally,
a repeated measure ANOVA was used to determine differences that may exist between age
groups. Statistical significance was set at α = .05. Demographic information was presented as
means ± SD.
Results
Participants Characteristics
A total of 44 adults completed the study. This included 24 young adults (26.5 + 7.4 years)
and 20 older adults (79.3 + 6.4 years). Overall, the sample was 64% female (28 subjects) and
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75% of participants were college or trade school graduates. Not all web-camera VPC data were
able to be scored due to technical difficulties, which included poor recording quality or network
connectivity, glare from glasses, and/or low light in the testing room. Of the 44 participants who
completed the assessment, 98% of the 30-min VPC scores were evaluated, 100% of Trial 1 and
88.5% of the Trial 2 of the 5-min VPC tests were analyzed. On average, the second trial session
took place 22.4 days after the first. Table 1 displays the characteristics of the study cohort.
Table 1
Characteristics of the study cohort (n = 44).
Young Adults

Older Adults

N

24

20

Average age (years)

26.5 ± 7.4

79.3 ± 6.4

Sex
N Female (%)

Significance
(p)

p < .001
p = .87

15 (62.5%)

13 (65.0%)

Education

p = .08

High School Graduate

4.2%

5.0%

Some College

29.2%

10.0%

College Graduates or
higher

66.7%

85%

Race

p = .21

European-American

83.3%

95.0%

Other

16.7%

5.0%

Height (cm)

170.1 ± 8.6

166.5 ± 8.6

p = .38

Weight (kg)

74.5 ± 17.8

73.2 kg ± 14.3

p = .96

Biometric

*Note. p-values were measured by independent t-tests to determine differences between
groups.
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Relationship between the 30-min VPC and 5-min VPC Tests
Among the young adults, analysis displayed a significant positive relationship between
the 30-min VPC and 5-min VPC tests. The 30-min VPC was significantly correlated with the 5min VPC during the first (r = .601; p = .003) and second (r = .722; p = .001) trials. This shows
the validity of the 5-min VPC test and its ability to measure declarative memory.
Reliability of the 5-min VPC Test
The results of Trial 1 were positively correlated to the Trial 2 results for the 5-min VPC
test (r = .81; p = .00). This shows the reliability of the assessment. Furthermore, there was no
significant difference between Trial 1 and 2 for the 5-min VPC test (p = .80). Mean scores for
Trial 1 and 2 were .812 and .808, respectively.
Comparing 5-min VPC Test Scores Between Young and Older Adults
Repeated measures ANOVA revealed no change over time between young and older
subjects for the 5-min VPC assessment (F = 3.16, p = .08; Figure 1). Mean VPC values were
83% (young adults, 81%; older adults, 85%) and 80% (young adults, 81%; older adults, 80%) for
Trials 1 and 2, respectively (Figure 2).

Figure 1. The time effect interaction of 5-min VPC Trial 1 and 2, between the young and older
adults.
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Figure 2. The mean values of the 5-min VPC, Trial 1 and 2, for the young and older adults.
Associations Between the 5-min VPC Test and Other Cognitive Assessments
Using cognitive function as a specific domain, the correlation between the 5-min VPC
test and the NIH Toolbox assessments was examined. The age-based normative percentile scores
were used to compare each task to the performance of the 5-min VPC test. During Trial 1 (Table
2), there was a significant relationship between the 5-min VPC and DCCS (r = .31; p = .03),
MoCA (r = .50, p = .00), and Digit Symbol Coding (r = .47, p = .00), but not the Flanker (r =
.14, p = .33), PCPST (r = .22, p = .14) or PSMT (r = -.09, p = .55). During Trial 2 (Table 3),
significant correlations were found between the 5-min VPC test and Flanker (r = .38, p < .01),
PCPST (r = .52, p = .00), PSMT (r = .49, p < .01), MoCA (r = .65, p = .00), and Digit Symbol
Coding (r = .57, p = .00), but not DCCS (r = .23, p = .12), dual-task habitual speed (r = -.24, p =
.09), or dual-task maximal speed (r = .02, p = .88).

17

Table 2.
Correlations between 5-min VPC test data from Trial 1 and cognitive assessments from Trial 1.
VPC-5

VPC-30

Flanker

DCCS

PCPST

PSMT

MoCA

VPC-5

-

VPC-30

.55**

-

Flanker

.14

-.09

-

DCCS

.31*

.00

.62**

-

PCPST

.21

.20

.61**

.52**

-

PSMT

.09

.13

.32*

.28*

.35*

-

MoCA

.50**

.26

.47**

.27*

.57**

.39**

-

DSC

.47**

.35**

.45**

.47**

.43**

.58**

.51**

DSC

-

Note. *p < .05; ** p < .01; Flanker = Flanker Inhibitory Control Test, DCCS = Dimension
Change Card Sort Test, PCPST = Pattern Comparison Processing Speed Test, PSMT = Picture
Sequence Memory Test, MoCA = Montreal Cognitive Assessment, DSC =Digit Symbol Code
Test
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Table 3.
Correlations between 5-min VPC test data from Trial 2 data and cognitive assessments from
Trial 2.
VPC-5

VPC-30

Flanker

DCCS

PCPST

PSMT

MoCA

DSC

DT-HS

VPC-5

-

VPC-30

.49**

-

Flanker

.38**

.09

-

DCCS

.23

.03

.60**

-

PCPST

.52**

.17

.56**

.57**

-

PSMT

.49**

.27

.09

.25

.33*

-

MoCA

.65**

.26

.39**

.35*

.58**

.51**

-

DSC

.57**

.31*

.54**

.40**

.68**

.43**

.57**

-

DT-HS

-.24

-.17

-.32*

-.20

-.32*

-.37*

.39**

.32*

-

DT-MS

.02

.11

-.20

-.18

-.19

.09

-.02

-.02

.13

DT-MS

-

Note. *p < .05; ** p < .01; Flanker = Flanker Inhibitory Control Test, DCCS = Dimension
Change Card Sort Test, PCPST = Pattern Comparison Processing Speed Test, PSMT =
Picture Sequence Memory Test, MoCA = Montreal Cognitive Assessment, DSC =Digit
Symbol Code Test, DT-HS = Dual-task Habitual, DT-MS = Dual-task maximal speed

Discussion
The four primary objectives of this study were to: 1) validate the 5-minute web-camera
based VPC test using the 30-min VPC test, 2) determine the test-retest reliability of the 5-min
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test, 3) compare the 5-min VPC test scores of the young adults (18-39 years of age) to the scores
of the older adults (>60 years of age), and 4) examine the relationship between the 5-min VPC
test and additional cognitive assessments. Among young adults, the results showed adequate
validity between the 5-min VPC and 30-min VPC test. The 5-min VPC scores were also
significantly correlated between trials, with no significant differences between Trial 1 and Trial
2. Not only is the 5-min VPC test shorter, but it is an active test (i.e. participants are instructed to
look at the new image), which differs from the passivity of the 30-min VPC test. This is
important because the 5-min VPC is intended to be taken repeatedly over time, rather than solely
being used as a baseline measure. This eliminates the need to conceal what the test is measuring
from the participant. Furthermore, the duration of the 5-min VPC lessens the stress on the
participant and increases the practicality of test administration.
There was a significant time effect, between trial scores for the 5-min VPC test.
However, the differences between the groups over time was not significant. This means the
changes in scores, from Trial 1 to Trial 2, did not differ between age groups. Statistically, the
group by time interaction is not significant, but amongst the older adults specifically, the
interaction is trending toward significance.
The 5-min VPC showed to be significantly related to standard cognitive assessments,
which suggests the 5-min VPC may be used as a convenient alternative to the longer cognitive
assessments. This supports the results of previous research which has shown a strong relationship
between VPC and other cognitive assessments among the older adult population, supporting the
specific ability of VPC tests to assess processing speed (PCPST), visual episodic memory
(PSMT), and executive function (Digit Symbol Coding) (Bott et al., 2018). Additionally,
learning effects associated with the repetitive administration of cognitive assessments has been
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shown to potentially cause issues with internal validity (Goldberg, Harvey, Wesnes, Snyder, &
Schneider, 2015). This is the case when administering NIH Toolbox assessments and Digit
Symbol Coding multiple times, due to the availability of only one version of each assessment
(Heaton et al., 2014). The minimum of 14 days between trials aims to alleviate the learning
effect. The learning effect in the 5-min VPC was reduced by the use of alternate forms of the test
during Trial 1 and 2.
The issue of data quality of the VPC tests serves as a limitation of this study. A total of
six VPC tests were not able to be scored due to glare from glasses, poor lighting in the testing
room, and/or electronic errors. The tests that were excluded were: the 30-min VPC of one young
adult and the 5-min VPC trial 2 assessments of five young adults. The subjects completed both
visits at the testing center, so they were still included in the overall analyses. The assessments
were completed in a research setting, to ensure high quality data collection, limiting the
ecological validity of the results. This study included only individuals with normal cognitive
function. Further research including individuals with cognitive impairment, as well as the
investigation of varying levels within individuals with cognitive impairment, is needed to further
validate VPC and its ability to assess cognition among all populations. Additionally, a
longitudinal study tracking participants overtime, exclusively utilizing the 5-min VPC test,
would verify the ability of VPC administration in clinical settings, to track cognition throughout
a lifetime.
Threats to Validity
The results of the cognitive tests were based off the participants willingness to complete
the tests to the best of their abilities. If this was not done, it is a possible threat to the internal
validity of the tests. The possible malfunction of technology may pose as a threat, however the
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manual analysis of VPC eye tracking ensured greater accuracy. The recruitment for the young
adults was done through the university, meaning it is possible a large sum of participants were
educated, either pursuing a bachelor's or graduate degree. This may have affected the overall
scores for the cognitive tests, which does not represent the general population. This affected the
comparison of the 5-min VPC scores to the cognitive test scores. However, this did not affect the
results of the test-retest reliability and the validity of the VPC results.
Assumptions
It is assumed the participants completed all cognitive tests as quickly as possible and to
the best of their ability. Furthermore, the participants were expected to pay attention throughout
the entirety of the VPC tests. It is also assumed participants did not suffer from cognitive
impairments, which was screened for using the medical history questionnaire and MoCA.
Limitations
The 30-min VPC test was only administered during the first trial. Even though a
crossover design was used, it is possible mental fatigue may have affected the scores of the
participants who were required to complete the NIH cognitive assessments after the 30-min test.
Delimitations
The following are delimitations of the current study. A total of 44 subjects participated in
the study. Cognitive assessments were completed using both paper-pencil tests and the NIH
toolbox on an iPad. Subjects were tested in the Exercise Science Research Center at the
University of Arkansas, or at Butterfield Trail Village. The trials were administered at least 14
days apart in order to determine test-retest reliability.
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Conclusion
Among the young adults, the 5-min VPC test demonstrated a moderate convergent
validity to the 30-min VPC, along with strong test-retest reliability. Between groups, there was a
significant time interaction, with group by time effect trending in significance. The significant
relationships between the 5-min VPC and the other cognitive assessments verifies previous
research, specifically supporting its ability to assess processing speed, visual episodic memory,
and executive function (Bott et al., 2018). Furthermore, the cohort included both older and young
adults, generalizing the results to a greater population.
The scalability of the 5-min VPC test may be greater than other cognitive assessments
due to its short duration, lessened strain on participants, and convenience of digital delivery.
Unlike other cognitive assessments, test administration by a trained professional is not needed
(Heaton et al., 2014). The 5-min VPC test can be completed anywhere with an internet
connection and web-camera, with minimal instructions required (Bott et al., 2018). This is not a
diagnostic test for cognitive impairment, but rather a screening tool used as a baseline and way to
monitor cognition over time in healthy individuals. The efficacy of testing individuals with
cognitive impairment, as well as testing in remote environments, requires further investigation.
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